ErbB4 deficiency exacerbates olfactory dysfunction in an early-stage Alzheimer's disease mouse model

被引:0
|
作者
Deng, Xian-hua [1 ,2 ]
Liu, Xing-yang [1 ,2 ]
Wei, Yi-hua [1 ,2 ]
Wang, Ke [1 ,2 ]
Zhu, Jun-rong [1 ]
Zhong, Jia-jun [1 ]
Zheng, Jing-yuan [1 ]
Guo, Rui [1 ]
Zhu, Yi-fan [1 ]
Ye, Qiu-hong [1 ]
Wang, Meng-dan [1 ]
Chen, Ying-jie [1 ]
He, Jian-quan [3 ]
Chen, Ze-xu [1 ]
Huang, Shu-qiong [1 ]
Lv, Chong-shan [1 ]
Zheng, Guo-qing [2 ]
Liu, Sui-feng [3 ]
Wen, Lei [1 ]
机构
[1] Xiamen Univ, Affiliated Hosp 1, Inst Neurosci, Ctr Brain Sci,State Key Lab Cellular Stress Biol,F, Xiamen 361000, Peoples R China
[2] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Zhejiang Prov Hosp Chinese Med, Dept Neurol, Hangzhou 310006, Peoples R China
[3] Xiamen Univ, Zhongshan Hosp, Sch Med, Xiamen, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; olfactory impairment; NRG1/ErbB4; signaling; GABAergic transmission; excitation/inhibition (E/I) imbalance; BULB; INTERNEURONS; NEUREGULIN-1; IMPAIRMENT; MODULATION; AMYGDALA; NEURONS; ANXIETY; PROTEIN; SYSTEM;
D O I
10.1038/s41401-024-01332-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Olfactory dysfunction is increasingly recognized as an early indicator of Alzheimer's disease (AD). Aberrations in GABAergic function and the excitatory/inhibitory (E/I) balance within the olfactory bulb (OB) have been implicated in olfactory impairment during the initial stages of AD. While the neuregulin 1 (NRG1)/ErbB4 signaling pathway is known to regulate GABAergic transmission in the brain and is associated with various neuropsychiatric disorders, its specific role in early AD-related olfactory impairment remains incompletely understood. This study demonstrated that olfactory dysfunction preceded cognitive decline in young adult APP/PS1 mice and was characterized by reduced levels of NRG1 and ErbB4 in the OB. Further investigation revealed that deletion of ErbB4 in parvalbumin interneurons reduced GABAergic transmission and increased hyperexcitability in mitral and tufted cells (M/Ts) in the OB, thereby accelerating olfactory dysfunction in young adult APP/PS1 mice. Additionally, ErbB4 deficiency was associated with increased accumulation of A beta and BACE1-mediated cleavage of APP, along with enhanced CDK5 signaling in the OB. NRG1 infusion into the OB was found to enhance GABAergic transmission in M/Ts and alleviate olfactory dysfunction in young adult APP/PS1 mice. These findings underscore the critical role of NRG1/ErbB4 signaling in regulating GABAergic transmission and E/I balance within the OB, contributing to olfactory impairment in young adult APP/PS1 mice, and provide novel insights for early intervention strategies in AD.This work has shown that ErbB4 deficiency increased the burden of A beta, impaired GABAergic transmission, and disrupted the E/I balance of mitral and tufted cells (M/Ts) in the OB, ultimately resulting in olfactory dysfunction in young adult APP/PS1 mice. NRG1 could enhance GABAergic transmission, rescue E/I imbalance in M/Ts, and alleviate olfactory dysfunction in young adult APP/PS1 mice. OB: olfactory bulb, E/I: excitation/inhibition, Pr: probability of release, PV: parvalbumin interneurons, A beta: beta-amyloid, GABA: gamma-aminobutyric acid.
引用
收藏
页码:2497 / 2512
页数:16
相关论文
共 50 条
  • [31] Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease
    Villarejo-Galende, Alberto
    Garcia-Arcelay, Elena
    Pinol-Ripoll, Gerard
    del Olmo-Rodriguez, Antonio
    Vinuela, Felix
    Boada, Merce
    Franco-Macias, Emilio
    Ibanez de la Pena, Almudena
    Riverol, Mario
    Puig-Pijoan, Albert
    Abizanda-Soler, Pedro
    Arroyo, Rafael
    Baquero-Toledo, Miquel
    Feria-Vilar, Inmaculada
    Balasa, Mircea
    Berbel, Angel
    Rodriguez-Rodriguez, Eloy
    Vieira-Camposs, Alba
    Garcia-Ribas, Guillermo
    Rodrigo-Herrero, Silvia
    Terrancle, Angeles
    Prefasi, Daniel
    Lleo, Alberto
    Maurino, Jorge
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 90 (02) : 719 - 726
  • [32] Evaluation of an Education and Support Program for Early-Stage Alzheimer's Disease
    Roberts, J. Scott
    Silverio, Elaine
    JOURNAL OF APPLIED GERONTOLOGY, 2009, 28 (04) : 419 - 435
  • [33] Early-stage Alzheimer?s disease: are skeletal muscle and exercise the key?
    Brisendine, Matthew H.
    Drake, Joshua C.
    JOURNAL OF APPLIED PHYSIOLOGY, 2023, 134 (03) : 515 - 520
  • [34] A literature review of spirituality in coping with early-stage Alzheimer's disease
    Beuscher, Linda
    Beck, Cornelia
    JOURNAL OF CLINICAL NURSING, 2008, 17 (5A) : 88 - 97
  • [35] The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders
    Sundermann, Erin E.
    Fields, Adam
    Saloner, Rowan
    Gouaux, Ben
    Bharti, Ajay
    Murphy, Claire
    Moore, David J.
    AIDS, 2021, 35 (03) : 429 - 437
  • [36] Hyperactivity of medial prefrontal cortex pyramidal neurons occurs in a mouse model of early-stage Alzheimer's disease without β-amyloid accumulation
    Choudhury, Nasreen
    Chen, Lihua
    Al-Harthi, Lena
    Hu, Xiu-Ti
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [37] Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model
    Karuppagounder, Saravanan S.
    Xu, Hui
    Shi, Qingli
    Chen, Lian H.
    Pedrini, Steve
    Pechman, David
    Baker, Harriet
    Beal, M. Flint
    Gandy, Sam E.
    Gibson, Guy E.
    NEUROBIOLOGY OF AGING, 2009, 30 (10) : 1587 - 1600
  • [38] MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
    Maximilian Pohland
    Maren Pellowska
    Heike Asseburg
    Stephanie Hagl
    Martina Reutzel
    Aljoscha Joppe
    Dirk Berressem
    Schamim H. Eckert
    Mario Wurglics
    Manfred Schubert‐Zsilavecz
    Gunter P. Eckert
    Alzheimer's Research & Therapy, 10
  • [39] Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model
    Stam, Cornelis Jan
    de Haan, Willem
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 99 (04) : 1333 - 1348
  • [40] MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease
    Pohland, Maximilian
    Pellowska, Maren
    Asseburg, Heike
    Hagl, Stephanie
    Reutzel, Martina
    Joppe, Aljoscha
    Berressem, Dirk
    Eckert, Schamim H.
    Wurglics, Mario
    Schubert-Zsilavecz, Manfred
    Eckert, Gunter P.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10